The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment

The marked differences in IGF and IGFBP levels between patients with HCC, liver cirrhosis and healthy subjects are mainly explained by variations in liver status. Therefore, this study questions the clinical utility of circulating IGF variables as markers of HCC.